US 11,773,063 B1
Pharmaceutically acceptable salts and compositions thereof
Jason Gray, Oxford (GB); Susana Del Rio Gancedo, Oxford (GB); Dita Davis, Oxford (GB); David James Pearson, Oxford (GB); and Daniel Rixson, Oxford (GB)
Assigned to Beckley Psytech Limited, Oxford (GB)
Filed by BECKLEY PSYTECH LIMITED, Oxford (GB)
Filed on Sep. 9, 2022, as Appl. No. 17/941,410.
Claims priority of application No. 2212116 (GB), filed on Aug. 19, 2022.
Int. Cl. C07D 209/16 (2006.01)
CPC C07D 209/16 (2013.01) [C07B 2200/13 (2013.01)] 10 Claims
 
1. A non-hygroscopic salt of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), wherein the non-hygroscopic salt is 5-MeO-DMT hydrobromide and the non-hygroscopic salt is in crystalline form.